The U.S. Food and Drug Administration (FDA) delayed a decision on whether to approve Moderna’s CCP virus vaccine for children aged 12 and older, according to the pharmaceutical giant on Sunday. The health regulator is investigating the risk of myocarditis, a form of heart inflammation, in children aged 12 to 17, Moderna’s statement said. The review…
FDA Delays Decision on Moderna Vaccine for Children aged 12 and Up: Company
Moderna Chairman Says COVID-19 Booster Could Be Yearly
The chairman and co-founder of drugmaker Moderna, Noubar Afeyan, said Tuesday that yearly COVID-19 vaccine boosters may be required in the future. In an interview with Fox News’ “Mornings with Maria,” Afeyan said that if the CCP (Chinese Communist Party) virus becomes endemic—having a constant presence in the world, in certain areas or populations—a regular booster…
US Defense Contractor Will Lose ‘Several Thousand People’ Over COVID Vaccine Mandate: CEO
The CEO of Defense Department contractor Raytheon said that the White House COVID-19 mandate will cause the firm to lose “several thousand” employees who will not take the vaccine. “We will lose several thousand people,” Raytheon Chief Executive Greg Hayes said during an interview Tuesday. He said that the company, which has about 125,000 workers…
Moderna to Supply Africa With up to 110 Million COVID Doses
NAIROBI, Kenya—Moderna on Tuesday said it will make up to 110 million doses of its COVID-19 vaccine available to African countries. The announcement said Moderna is prepared to deliver the first 15 million doses by the end of this year, with 35 million in the first quarter of 2022 and up to 60 million in…
Moderna to Supply Africa With up to 110 Million COVID-19 Doses
NAIROBI, Kenya—Moderna on Tuesday said it will make up to 110 million doses of its COVID-19 vaccine available to African countries. The announcement said Moderna is prepared to deliver the first 15 million doses by the end of this year, with 35 million in the first quarter of 2022 and up to 60 million in…
Moderna Says Its COVID-19 Vaccine Effective, Safe in Children Ages 6 to 11
Moderna said Monday that its COVID-19 vaccine is able to generate a strong immune response in children ages 6 to 11, citing a new study. The company said that an interim analysis of data showed a “robust neutralizing antibody response” after two shots of its mRNA-1273 vaccine were administered at a 50 microgram dose level,…
Sweden Extends Pause of Moderna Vaccine for Under-30s Due to Heart-Related Side Effects
Sweden has extended its pause of the Moderna COVID-19 vaccine for people aged 30 and younger due to heart-related side-effects, the public health agency announced on Oct. 21. The European Medicines Agency approved the use of Moderna’s Spikevax for children aged over 12 in July, marking the first time the shot had been authorized for use in people…
FDA Authorizes Moderna, J&J Booster Shots, ‘Mix and Match’ Approach
The Food and Drug Administration (FDA) on Wednesday authorized booster shots for Moderna and Johnson & Johnson vaccines for certain eligible populations, adding that people can take a different vaccine brand than the ones they’d taken originally. The booster campaign for those aged 65 and over and those at high risk aims to increase protection against COVID-19…
NTD Evening News Full Broadcast (Oct. 14)
LinkedIn becomes the latest U.S. social media platform to leave the Chinese market, an FDA panel votes on Moderna booster shots, and a medical expert for CNN says the network misrepresented a drug.
FDA Panel Unanimously Recommends Authorization of Moderna COVID-19 Vaccine Booster
A Food and Drug Administration (FDA) advisory panel voted unanimously on Thursday to recommend the agency let millions of Americans get a booster of Moderna’s COVID-19 vaccine. The 19–0 vote came after hours of discussions and presentations in an all-virtual meeting. Moderna officials presented data from clinical trials, including a small trial that studied the…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`